+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

North America Poultry Vaccines Market Forecast to 2031 - Regional Analysis - by Type, Technology, Dosage Form, Disease, Route Of Administration, and End User

  • PDF Icon

    Report

  • 117 Pages
  • October 2024
  • Region: North America
  • The Insight Partners
  • ID: 6026486
UP TO OFF until Dec 31st 2024
The North America poultry vaccines market was valued at US$ 702.04 million in 2023 and is expected to reach US$ 1.32 billion by 2031; it is estimated to record a CAGR of 8.3% from 2023 to 2031.

Rising Prevalence of Poultry Diseases Fuels North America Poultry Vaccines Market

Poultry production results in producing different types of animal proteins through eggs and meat. With rising poultry production, there are high chances of susceptibility to several zoonotic diseases such as “Fowl disease” that might result in huge economic losses, particularly in developing countries. For example, chickens are more prone to bacterial, viral, parasitic, and fungal infections. These viral outbreaks can cause Newcastle Disease, Avian Influenza, Infectious Bursal Disease, and other diseases in other poultry animals.

The table below provides disease outbreaks of Avian Influenza among mammals across Canada in 2022.

Cases of Avian Influenza in Mammals

Country

Poultry Diseases

Disease Outbreak (2022)

Canada

40

Canada

H5N5

2

Source: World Organization for Animal Health 2023

Poultry diseases are a major cause of death of chicks and also lead to reduced livestock productivity of chickens. Farmers are facing huge economic losses worldwide as they spread zoonotic diseases, posing a serious health risk to mammals. For example, poultry coccidiosis is one of the most common diseases across the globe; it leads to huge losses associated with mortality, reduced body weight, and extra expenses related to preventive and therapeutic control. As per the DSM company website, farmers face an economic loss of US$ 3 billion annually owing to coccidiosis in chickens and avian species worldwide. Newcastle disease is also considered an economically expensive disease causing huge production losses to the farmers of developing countries that export poultry products.

Therefore, the rising prevalence of poultry diseases resulting in huge economic losses boosts the demand for poultry vaccinations, which drives the market.

North America Poultry Vaccines Market Overview

North America accounts major share for poultry vaccines market. Among the North America regional market, US accounts maximum share due to presence of top companies in the country and well-established centers providing vaccination services. Such aforementioned facts are one of the key factors that influence market growth in the region for the forecast period.

North America Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)

North America Poultry Vaccines Market Segmentation

The North America poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.

Based on type, the North America poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.

In terms of technology, the North America poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.

By dosage form, the North America poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.

Based on disease, the North America poultry vaccines market is segmented into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023.

In terms of route of administration, the North America poultry vaccines market is categorized into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.

Based on end user, the North America poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.

By country, the North America poultry vaccines market is segmented into the US, Canada, and Mexico. The US dominated the North America poultry vaccines market share in 2023.

Starkey Laboratories Inc., Audina Hearing Instruments Inc, Sebotek Hearing Systems LLC, Earlens Corp, GN Store Nord AS, Cochlear Ltd, WS Audiology AS, Sonova Holding AG, Sonic Innovations Inc, and Amplifon Hearing Health Care Corp. are some of the leading companies operating in the North America poultry vaccines market.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
4. North America Poultry Vaccines Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Poultry Diseases
4.1.2 Growing Poultry Industry
4.2 Market Restraints
4.2.1 Vaccination Failure and Improper Handling
4.3 Market Opportunities
4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
4.4 Future Trends
4.4.1 Advancements in Vectored and Combination Vaccines
4.5 Impact of Drivers and Restraints:
5. North America Poultry Vaccines Market Analysis
5.1 Poultry Vaccines Market Revenue (US$ Million), 2023-2031
6. North America Poultry Vaccines Market Analysis - by Type
6.1 Overview
6.2 Broiler
6.2.1 Overview
6.2.2 Broiler: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Layer
6.3.1 Overview
6.3.2 Layer: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
7. North America Poultry Vaccines Market Analysis - by Technology
7.1 Overview
7.2 Live Attenuated Vaccines
7.2.1 Overview
7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Inactivated Vaccines
7.3.1 Overview
7.3.2 Inactivated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Recombinant Vaccines
7.4.1 Overview
7.4.2 Recombinant Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
8. North America Poultry Vaccines Market Analysis - by Dosage Form
8.1 Overview
8.2 Liquid Vaccines
8.2.1 Overview
8.2.2 Liquid Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Freeze-Dried Vaccines
8.3.1 Overview
8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Dust/Powdered Vaccines
8.4.1 Overview
8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9. North America Poultry Vaccines Market Analysis - by Disease
9.1 Overview
9.2 Avian Influenza
9.2.1 Overview
9.2.2 Avian Influenza: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Salmonellosis
9.3.1 Overview
9.3.2 Salmonellosis: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Marek's Disease
9.4.1 Overview
9.4.2 Marek's Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Infectious Bronchitis (IB)
9.5.1 Overview
9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Infectious Bursal Disease (IBD)
9.6.1 Overview
9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.7 Newcastle Disease
9.7.1 Overview
9.7.2 Newcastle Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10. North America Poultry Vaccines Market Analysis - by Route of Administration
10.1 Overview
10.2 Drinking Water (D/W)
10.2.1 Overview
10.2.2 Drinking Water (D/W): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Intramuscular (I/M)
10.3.1 Overview
10.3.2 Intramuscular (I/M): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Subcutaneous (S/C)
10.4.1 Overview
10.4.2 Subcutaneous (S/C): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
11. North America Poultry Vaccines Market Analysis - by End User
11.1 Overview
11.2 Poultry Farms
11.2.1 Overview
11.2.2 Poultry Farms: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Veterinary Hospitals
11.3.1 Overview
11.3.2 Veterinary Hospitals: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Poultry Vaccination Centers and Clinics
11.4.1 Overview
11.4.2 Poultry Vaccination Centers and Clinics: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
12. North America Poultry Vaccines Market - Country Analysis
12.1 North America Market Overview
12.1.1 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
12.1.1.1 United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.1.1 Overview
12.1.1.1.2 United States: Poultry Vaccines Market Breakdown by Type
12.1.1.1.3 United States: Poultry Vaccines Market Breakdown by Technology
12.1.1.1.4 United States: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.1.5 United States: Poultry Vaccines Market Breakdown by Disease
12.1.1.1.6 United States: Poultry Vaccines Market Breakdown by Route Of Administration
12.1.1.1.7 United States: Poultry Vaccines Market Breakdown by End User
12.1.1.2 Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.2.1 Overview
12.1.1.2.2 Canada: Poultry Vaccines Market Breakdown by Type
12.1.1.2.3 Canada: Poultry Vaccines Market Breakdown by Technology
12.1.1.2.4 Canada: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.2.5 Canada: Poultry Vaccines Market Breakdown by Disease
12.1.1.2.6 Canada: Poultry Vaccines Market Breakdown by Route Of Administration
12.1.1.2.7 Canada: Poultry Vaccines Market Breakdown by End User
12.1.1.3 Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 Overview
12.1.1.3.2 Mexico: Poultry Vaccines Market Breakdown by Type
12.1.1.3.3 Mexico: Poultry Vaccines Market Breakdown by Technology
12.1.1.3.4 Mexico: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.3.5 Mexico: Poultry Vaccines Market Breakdown by Disease
12.1.1.3.6 Mexico: Poultry Vaccines Market Breakdown by Route Of Administration
12.1.1.3.7 Mexico: Poultry Vaccines Market Breakdown by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Poultry Vaccines Market
13.3 Organic Developments
13.3.1 Overview
13.1 Inorganic Developments
13.1.1 Overview
14. Company Profiles
14.1 Boehringer Ingelheim International GmbH
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Zoetis Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Phibro Animal Health Corp
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Dechra Pharmaceuticals PLC
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Elanco Animal Health Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck KGaA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Ceva
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Vaccinova AB
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms

Companies Mentioned

  • Boehringer Ingelheim International GmbH.
  • Zoetis Inc.
  • Phibro Animal Health Corp.
  • Dechra Pharmaceuticals PLC.
  • Elanco Animal Health Inc.
  • Merck KGaA.
  • Ceva.
  • Vaccinova AB.

Table Information